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Title: Verification of analytical methods for GMO testing when implementing interlaboratory validated methods 
 
Abstract 
In the EU, method validation is an essential part of the process that regulates the introduction of new GMOs as 
food and/or feed into the market. When the inter-laboratory validation study is completed, the method is ready 
to be implemented in routine testing laboratories.  
When implementing the new method, the laboratory has to verify that the method can be used for its intended 
purpose (method verification). The scope of this document is to provide guidance on how to carry out the 
method verification of inter-laboratory validated methods for the qualitative and quantitative detection of 
GMOs. Considering that the Polymerase Chain Reaction (PCR) is the method of choice in the EU for the 
identification and quantification of GMOs, this document refers exclusively to real time PCR. However, if novel 
methods are subsequently developed that fulfil legal requirements, then this document will be amended 
accordingly.  
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Executive summary 
In the EU, method validation is an essential part of the process that regulates the 
introduction of new GMOs as food and/or feed into the market. When the inter-laboratory 
validation study is completed, the method is ready to be implemented in routine testing 
laboratories.  
When implementing the new method, the laboratory has to verify that the method can be 
used for its intended purpose (method verification).  
The scope of this document is to provide guidance on how to carry out the method 
verification of inter-laboratory validated methods for the qualitative and quantitative 
detection of GMOs.  
Considering that the Polymerase Chain Reaction (PCR) is the method of choice in the EU 
for the identification and quantification of GMOs, this document refers exclusively to real 
time PCR. However, if novel methods are subsequently developed that fulfil legal 
requirements, then this document will be amended accordingly.  
This document provides the definitions of the parameters to be assessed by laboratories 
in a verification study and the related acceptance criteria. Moreover, indications and 
examples of experimental designs are also described. 
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Scope of the report 
The first working group on method verification was established on the basis of a mandate adopted 
by the ENGL Steering Committee on 19th - 20th of November 2009.  
The working group was chaired by Lotte Hougs, Danish Veterinary and Food administration (DVFA) 
Ringsted, Denmark and Jana Žel, National Institute of Biology (NIB), Ljubljana, Slovenia. The other 
members of the working group have been: Chrystele Charles-Delobel, Joint Research Centre (JRC); 
Malcolm Burns, LGC, United Kingdom; Diana Charels, Joint Research Centre (JRC); Ilaria Ciabatti, 
Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana, Italy; Encarnacion Luque-Perez, 
Joint Research Centre (JRC); Joachim Mankertz, Bundesamt für Verbraucherschutz und 
Lebensmittelsicherheit (BVL), Germany; Marco Mazzara, Joint Research Centre (JRC); Frank 
Narendja, Umweltbundesamt, Austria; Martin Sandberg, NFA-National Food Administration, 
Uppsala, Sweden; Manuela Schulze, LAVES, Germany; Cristian Savini, Joint Research Centre 
(JRC); Ingrid Scholtens, RIKILT Wageningen University & Research, The Netherlands and Thomas 
Weber, Joint Research Centre (JRC). 
The mandate of the working group was to develop a guideline for the implementation of validated 
methods in control laboratories under ISO 17025:2005 accreditation taking into account the 
demands outlined in the ENGL guidelines and in particular the “Definition of minimum performance 
requirements for analytical methods of GMO testing” version 13/10/2008.    
The resulting guideline 'Verification of analytical methods for GMO testing when implementing 
interlaboratory validated methods' was published in July 2011.  
The 30th ENGL Steering Committee, held on 3rd - 4th of February 2016, established the working 
group on “Update of Method Verification Document” with the mandate of: 
 Update the document to include verification criteria for techniques not currently covered. 
 Align the document to the new version of the ENGL guideline “Definition of minimum 
performance requirements for analytical methods of GMO testing”1. 
 Review the terminology, also considering the new ISO 16577:20162. 
The working group has been chaired by Lotte Hougs, Danish Veterinary and Food administration 
(FVST) Ringsted, Denmark. The other members of the working group have been Francesco Gatto, 
Joint Research Centre (JRC), European Commission; Ottmar Goerlich, Bavarian Health and Food 
Safety Authority, Germany; Lutz Grohmann, Federal Office of Consumer Protection and Food Safety 
(BVL), Germany; Kathrin Lieske, Federal Office of Consumer Protection and Food Safety (BVL), 
Germany; Marco Mazzara, Joint Research Centre (JRC), European Commission; Frank Narendja, 
Umweltbundesamt, Austria; Jaroslava Ovesná. Crop Research Institute, Czech Republic; Nina 
Papazova, Scientific Institute of Public Health (WIV-ISP), Belgium; Ingrid Scholtens, RIKILT 
Wageningen University & Research, The Netherlands and Jana Žel, National Institute of  Biology 
(NIB), Slovenia. 
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Introduction 
A new analytical method evolves through a number of actions. After the initial 
development and optimisation phases, a laboratory performs an in-house validation on 
the method to ensure that the method is fit for the intended purpose during internal use. 
Before the method can be accepted as fit for use by several laboratories or as an 
International Standard, it needs to be validated by a number of laboratories3,4. When this 
inter-laboratory validation study is successfully completed, the method is ready to be 
implemented in routine testing laboratories. When implementing the new method in such 
a laboratory, it has to be verified there that the method can be used for its intended 
purpose.  
Regulation (EU) No 625/20175 (repealing Regulation (EC) No 882/20046) provides that 
official control laboratories shall be accredited according to the ISO/IEC 17025:20057 
standard. Such an accreditation, under a fixed or flexible scope, implies that “the 
laboratory shall confirm that it can properly operate standard methods before introducing 
the tests or calibrations” and whenever "the standard method changes, the confirmation 
shall be repeated" (ISO/IEC 17025:2005, section 5.4.2). 
In GMO detection laboratories qualitative and quantitative methods with different levels 
of specificity are used (e.g. genetic element-, construct-, or event-specific). For the 
detection and quantification of GMOs in food and feed products, the event-specific 
detection methods provided in applications for authorisation in the frame of Regulation 
(EC) No 1829/20038 are validated by the European Union Reference Laboratory for 
Genetically Modified Food and Feed (EURL GMFF) in collaboration with the ENGL. These 
and other qualitative element-, construct- or event-specific methods are compiled in the 
GMOMETHODS database91 according to Article 94 of Regulation (EU) No 625/2017 (and 
Article 32 of Regulation No. 882/2004). The method validation has to be performed 
according to internationally recognized guidelines3,4 through collaborative studies. Data 
from the inter-laboratory validation of the methods are evaluated according to the 
document “Definition of Minimum Performance Requirements for Analytical Methods of 
GMO Testing”1 (MPR).  
Despite the fact that several guidelines1,10–13 and peer-reviewed papers14–17 on in-house 
method validation have been published, no specific guidelines are available for the 
verification of GMO detection methods.   
The aim of this document is to provide guidance and to harmonise the in-house 
verification of inter-laboratory validated methods for the qualitative and quantitative 
detection of GMOs, including element-, construct-, and event-specific methods.  
The principles of the modular approach18 have been taken into account in this document, 
therefore this guidance refers to the verification of the PCR module and not the DNA 
extraction module (Figure 1). Nonetheless, indications on the evaluation of the suitability 
of the extracted DNA solutions are given to facilitate the verification exercise. The 
approach to independently assess the modules is already used for method validation1,19, 
and allows laboratories to better suit the analytical procedures to different food and feed 
matrix materials.  
The validation of methods for GMO detection as well as procedures for the calculation of 
the measurement uncertainty are not within the scope of this document. 
Considering that the PCR is the method of choice in the EU for the identification and 
quantification of GMOs, this document refers exclusively to real-time PCR methods. If 
new methods, based on other technologies, will be developed that fulfil legal 
requirements, then this document will be amended accordingly.  
 
                                           
1 http://gmo-crl.jrc.ec.europa.eu/gmomethods/ 
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Terminology 
Amplification efficiency1 
The rate of amplification calculated from the slope of the standard curve obtained after a 
decadic semi-logarithmic plot of Cq values over the DNA copy numbers/quantity. The 
efficiency (in %) can be calculated by the following equation: 
Efficiency = (10 (-1/slope)-1) x 100 
Analytical sample20 
Sample prepared from the laboratory sample by grinding, if necessary, and 
homogenization (see also Fig. 1). 
Cq21 
The quantification cycle (Cq), also known as threshold cycle (Ct), is defined as the 
fractional cycle number at which the fluorescence generated by the amplification of a 
target DNA in a real time PCR experiment reaches a fixed threshold and so allows the 
quantification of the amount of target DNA.  
DNA extraction replicates (as used in this document) 
DNA extracted from different test portions from the same analytical sample. 
Dynamic range 
The range of concentrations over which the method provides a linear correlation between 
the measurement and the amount of the target, with an acceptable level of trueness and 
precision. 
Laboratory sample22  
Sample as received by the laboratory and intended for inspection or testing (see also Fig. 
1). 
Limit of detection (LOD)1 
LOD is the lowest amount or concentration of analyte in a sample, which can be reliably 
detected but not necessarily quantified. Experimentally, methods should detect the 
presence of the analyte for at least 95 % of the cases (samples) at the LOD, ensuring ≤ 
5 % false negative results. 
Limit of quantification (LOQ)1  
LOQ is the lowest amount or concentration of analyte in a sample, which can be reliably 
quantified with an acceptable level of precision and trueness.  
Multiplex PCR2 
PCR technique that employs multiple pairs of primers combined within a single reaction 
mixture to produce multiple amplicons. 
PCR replicates (as used in this document) 
PCR performed on the same DNA extraction replicate analysed in different reaction wells. 
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Probability of detection (POD)1 
The probability of a positive (i.e., presence detected) analytical outcome for a qualitative 
method for a given matrix at a given concentration. It is estimated by the expected ratio 
of positive to negative results for the given matrix at the given analyte concentration. 
Practical limit of detection (practical LOD)  
The practical LOD is the lowest quantity of GMO, expressed as mass fraction or DNA copy 
number ratio, that can be reliably detected in a sample, when a known number of the 
taxon (ingredient) genome copies has been determined or estimated.  
Practical limit of quantification (practical LOQ)  
The practical LOQ is the lowest quantity of GMO, expressed as mass fraction or DNA copy 
number ratio, that can be reliably quantified in a sample, when a known number of taxon 
(ingredient) genome copies has been determined or estimated.  
Precision – Relative repeatability standard deviation (RSDr)
1 
The relative standard deviation of test results obtained under repeatability conditions. 
Repeatability conditions are conditions where test results are obtained with the same 
method on identical test items in the same laboratory by the same operator using the 
same equipment within short intervals of time. RSDr is calculated by dividing the 
repeatability standard deviation by the mean of results. 
Repeatability standard deviation (SDr)
2 
Standard deviation of test results obtained under repeatability conditions. 
Relative repeatability standard deviation2 
See “Precision” 
R2 coefficient1 
R2 is the coefficient of determination, which is calculated as the square of the correlation 
coefficient (between the measured Cq-value and the decadic logarithm of the 
concentration) of a standard curve obtained by linear regression analysis. 
Robustness1 
The robustness of a method is a measure of its capacity to remain unaffected by small, 
but deliberate deviations from the experimental conditions described in the procedure. 
Specificity1   
The property of the method to respond exclusively to the characteristic or the analyte of 
interest. 
Test portion22 
Sample, as prepared for testing or analysis, the whole quantity being used for analyte 
extraction at one time (see also Fig. 1). 
Test result 
A test result is a Cq value or copy number concentration originating from a PCR replicate. 
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Trueness1 
The closeness of agreement between the average value obtained from a large series of 
test results and an accepted reference value. The measure of trueness is usually 
expressed in terms of bias. 
Validation of method7 
Validation is the confirmation by examination and provision of objective evidence that the 
particular requirements for a specific intended use are fulfilled. 
Verification of method11 
Provision of objective evidence that a laboratory can adequately operate a method, 
achieving the performance requirements for the sample matrices to which the method is 
being applied.  
Working DNA concentration  
The highest DNA concentration intended to be used in PCR analysis. 
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Figure 1: Illustration of replicates terminology 
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General considerations 
An accredited laboratory shall have a management system in place to provide objective 
evidence that the personnel is adequately qualified and regularly trained to perform the 
analysis (ISO/IEC 17025:2005, section 5.2). In addition, a metrology system shall 
ensure that the equipment used is periodically calibrated (ISO/IEC 17025:2005, section 
5.5). When an inter-laboratory validated method is used by an accredited laboratory, the 
laboratory has to ensure that the chosen method shows, prior to its use, performance 
characteristics in the laboratory similar to those attributed in the inter-laboratory study. 
The verification process must be documented and recorded in the quality system. 
The laboratory has to record the procedure used, the results obtained and a statement as 
to whether the method is fit for the intended use, i.e.: 
- Design and planning of the verification; 
- Description of the method; 
- Acceptance criteria and performance requirements, as decided by the laboratory; 
- Test records; 
- Assessment of the method. 
Inter-laboratory validated methods are assessed according to the acceptance criteria and 
performance requirements described in the document MPR1. This document can be more 
generally used also as a basis for assessing the performance results of a method in a 
verification process. The methods are available, e.g., in the GMOMETHODS database of 
the EURL GMFF23. The following sections describe the parameters to be studied for the 
verification of validated methods for the detection of GMOs. During the verification 
process, a laboratory should ensure compliance to the requirements described in the 
following standards: CEN/TS 15568:200620, ISO 24276:200622, ISO 21570:200524, ISO 
21569:200525 and ISO 21571:200526. 
As a matter of principle, a method should be implemented as validated in the inter-
laboratory trial without introducing modifications. If single elements, like e.g. the brand 
of a ready-to-use reaction mix or Taq polymerase, the PCR reaction volume, the primer 
and probe concentrations, and/or PCR cycling parameters are modified, additional 
performance parameters should be experimentally assessed (e.g. specificity and 
robustness). Guidelines can be found in Woll et al.27 and will also be published in the 
document “Guidelines on the update of GMO EURL GMFF validated methods” (in 
preparation). 
The verification process is usually conducted on a certified reference material (CRM). If 
CRMs are not available, other GM positive materials can be used, such as Proficiency Test 
samples or routine samples. A CRM certified for a specific event, can be used for 
element- or construct-specific method verification, if the event contains the element or 
construct, even when the CRM is not certified for the element or construct. 
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DNA extraction and purification 
Although this document focuses on the verification of PCR methods, the evaluation of 
DNA extraction methods is a crucial step, as the quality and quantity of DNA extracted 
may significantly affect the final result. The DNA isolation method should be assessed on 
a range of representative materials and provide DNA of suitable quality and quantity for 
subsequent analysis.  
Procedure: The DNA extraction method should be applied to the same material as for the 
validation study as well as to representative samples expected to be analysed. Even if 
the DNA extraction method was previously validated on a particular matrix, the DNA 
extraction shall be carried out at least twice (three times recommended) on 2 
independent test portions, if possible on different days and with different operators. The 
extracted DNA has to meet the acceptance criteria for DNA concentration and quality1 
(e.g. by controlling amplification efficiency and presence of inhibitors by real-time PCR). 
DNA extraction methods applied to one matrix may not be suitable for other matrices. 
This procedure may need to be carried out on different matrices. For the verification of a 
DNA extraction method the tested matrix does not necessarily have to contain GMO. 
 
DNA concentration 
Procedure:  
The DNA concentration can be determined by using fluorimetric or spectrophotometric 
techniques. It is recommended to use the same technique in the verification study as 
foreseen for the analyses of samples since the quantification of DNA could be affected by 
the method used28. 
Acceptance criterion: The method should provide DNA in an appropriate yield for the 
intended analysis (at least enough to meet the desired practical LOD/LOQ). Where 
applicable, the yield should be comparable to the results obtained in the validation study.  
If a DNA extraction method does not give an appropriate yield for the intended analysis 
on a particular matrix, the practical LOD will be affected (Annex 1). 
 
Purity of DNA extracts  
The isolation of the DNA may lead to the co-purification of substances that inhibit the 
PCR reaction resulting in the absence or a lower rate of amplification. In the first case, 
false negative results may be obtained or, as in the second case, the quantification of the 
analyte can be underestimated.  
Therefore, the laboratory needs to verify that the DNA extraction procedure guarantees 
the removal of such inhibitors.    
Procedure:  
The presence or absence of PCR inhibitors can be verified by testing different dilutions 
prepared from a DNA solution so that the more the DNA solution is diluted, the less is the 
concentration of inhibitors.  
Two or more dilution levels should be tested with a validated taxon-specific reference 
system (e.g. lectin for soybean DNA) with the first dilution level representing the 
'working DNA concentration', i.e. the total DNA amount per reaction intended to be used 
in the verification process and in routine analysis.  
After the completion of the amplification, the Cq value from the more concentrated DNA 
solution is compared to the Cq values of the other concentration levels and to the 
theoretical value computed by assuming the absence of PCR inhibitors. 
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Example 1: Each DNA extraction replicate is diluted to at least two different 
concentrations and analysed by using a taxon-specific assay. Then the difference 
between the average Cq from the most diluted and more concentrated portions is 
calculated (ΔCq) and compared to the theoretical ΔCq.  
 
Acceptance criterion:  
Example 1: The theoretical ΔCq for a 1:4 dilution is 2.0. The difference between the 
measured ΔCq value and the theoretical ΔCq (2.0) value of the sample should be <0.5.  
Annex 2 describes in more details an alternative inhibition assay and the calculation 
sheet is given as electronic supplementary material. 
If the extracted DNA contains inhibitors the DNA has to be further purified or diluted to 
the level where no inhibition of PCR reaction is observed, before it is used for real-time 
PCR. 
Specificity 
Specificity of a particular assay should already have been investigated in the context of 
method validation.  
Therefore, the specificity does not need to be re-investigated in a verification study, if 
the conditions of the assay (e.g. primers/probe concentration; annealing temperature; 
fluorescent dye) are unchanged.  
Data regarding specificity can be retrieved from the validation report or peer review 
articles, or from databases9,29–31. If these data are not available or cannot be retrieved, 
the method should be tested in-house. 
The method should be tested regarding responsiveness towards new GMO events that 
contain the target sequence. This can only be done when the respective positive control 
materials are available for the new GMO events.  
One has to consider that matrix reference materials are only certified for the presence or 
absence of a particular GM event and not for the absence or presence of other GM events 
that could be present as trace constituents.  
For procedure and details see the MPR1. 
Dynamic range, R2 Coefficient and Amplification Efficiency 
The dynamic range must cover the values expected for the specific application. Within 
the dynamic range, the standard curves should meet the acceptance criteria for the 
amplification efficiency and the R2. 
Procedure: Dynamic range, R2 coefficient, and amplification efficiency are verified 
simultaneously from standard curves when testing other parameters, such as trueness 
and precision. The average values of at least two standard curves should be taken (See 
Table 1 for details). 
 
Example: Dynamic range from 0.09 % (m/m) to 4.5 % (m/m) for a 0.9 % (m/m) GMO 
target concentration, or 50 to 2500 copies/reaction if the target is 500 copies/reaction. 
Acceptance criterion for amplification efficiency: The average value of the slope of the 
standard curve shall be in the range of -3.6 ≤ slope ≤ -3.1, corresponding to an 
amplification efficiency of 90 - 110 %1.  
Acceptance criterion for R2 coefficient: the average value of R2 shall be ≥ 0.981. 
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Trueness  
Procedure: The trueness should be determined at a content level close to the level set in 
legislation (e.g. threshold 0.9 % m/m), or according to the intended use of the method, 
and, if appropriate, additionally at a level close to the LOQ. The trueness can be assessed 
by using CRM. Usually two concentrations (e.g. 0.1 % and 1 % m/m) and, if possible, a 
third one at the upper end of the dynamic range (e.g. 5 % m/m) should be investigated. 
Alternatively, a reference sample could be prepared, preferably from a higher 
concentrated CRM. Annex 3 provides a guideline for the preparation of such a reference 
sample. 
The analytical procedure used including reaction volume, PCR instrument, etc. should be 
the same as during routine testing of samples. Results from at least 16 PCR replicates 
should be evaluated. Examples for possible test designs are shown in Table 1 and Figures 
2 and 3. 
Annex 4 provides guidelines for the calculation of the mean, standard deviation and 
relative repeatability standard deviation of GMO-content of related and unrelated real-
time PCR replicates. 
If CRMs for estimating the trueness are not available, a sufficiently characterized 
proficiency test material can be employed. However, the assigned value of the PT 
material shall be a reference value independently established outside the PT exercise, i.e. 
the GMO content established by a 'consensus value from participants' results' are not 
suitable for the estimation of the trueness.   
The laboratory result from a proficiency testing (PT) exercise may also be used under the 
conditions that a sufficiently characterized proficiency test material has been employed 
(see above) and that the standard deviation for PT assessment had been properly 
chosen.  
Acceptance criterion: The trueness of the own measurement results is within ± 25 % of 
the accepted reference value or a Z-score within the range of 2 and -2 has been obtained 
in a proficiency test using a sufficiently characterized proficiency test material. 
Relative Repeatability Standard Deviation (RSDr) 
Procedure: Repeatability can be determined in a similar way as described under 
Trueness. It is calculated from results obtained on PCR replicates run under repeatability 
conditions (see Terminology). Repeatability should be available for all tested GM-content 
levels.  
The analytical procedure used should be the same as during routine testing of samples. 
At least 16 single test results should be evaluated. Examples for possible test designs are 
shown in Table 1 and Figures 2 and 3. 
Annex 4 provides guidelines for the calculation of standard deviation and RSDr of GMO-
content of related and unrelated real-time PCR replicates. 
Acceptance criterion: The RSDr should be ≤ 25 %, over the dynamic range of the 
method. 
Note: For verification of methods intended to be used under Regulation (EU) No 
619/201132, the laboratory should demonstrate a relative repeatability standard deviation 
≤ 25 % established on samples containing 0.1 % GM related to mass fraction of GM 
material (see specific guidance33). 
Estimation of the Limit of Quantification (LOQ)  
An LOQ can be determined for a ratio, i.e. the mass fraction or DNA copy number ratio, 
as well as for the number of measurable DNA copies. 
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Procedure for Relative LOQ (LOQrel): the laboratory should demonstrate the capacity in 
reliably quantifying a sample at the 0.1 % m/m corresponding to the minimum 
concentration level tested in validation1. The experimental assessments are described in 
the sections for trueness and precision.  
Procedure for Absolute LOQ (LOQabs): A dilution series of known amounts of copies per 
reaction is tested in at least 10 PCR replicates (e.g. 80, 60, 40, 20, 10, 5 copies and 1 
copy per reaction). Then the RSDr is calculated for each dilution level. The LOQabs is 
estimated as the last dilution level where the RSDr of the measurements is below 25 %. 
Please note that the standard curve of the method should include the LOQabs.   
The probability distribution suggests that analysis at 1 copy per reaction should give 
approximately 30 % of negative results. In order to verify that the target copies per 
reaction of the dilution series are approximately correct, at least 1/10 of the replicates 
should provide negative results for analysis at 1 copy per reaction.  
Acceptance criterion: MPR Acceptance criterion: The LOQ should be ≤ the lowest amount 
of copies per reaction or ratio included in the dynamic range.  
Estimation of the Limit of Detection (LOD)  
The LOD can be determined for a ratio, i.e. mass fraction or DNA copy number ratio, as 
well as for the number of measurable DNA copies.  
To estimate the LOD of a method with 95 % confidence it is necessary to analyse at least 
60 PCR replicates for each tested concentration34,35. As this may not be feasible, a 
pragmatic approach based on a lower number of replicates could be followed for the 
verification of the LOD. This approach allows an approximate estimation of the LOD. 
Procedure for Relative LOD (LODrel): a reference material of low GM content can be 
measured in e.g. 10 PCR replicates and if all replicates are positive, this infers that the 
LODrel is below or equal to this content level. If needed, a reference material at a specific 
level could be prepared as described in Annex 3. 
Acceptance criterion: The LODrel should be in line with the validation data and/or the MPR 
document (< 0.045 % m/m with a 95 % confidence level)1. 
Procedure for Absolute LOD (LODabs): Dilution series representing the range above and 
below the expected LODabs, based on prior knowledge of the LODabs performance of that 
method, are tested in e.g. 10 PCR replicates for each concentration level. The lowest 
concentration where all replicates are positive is the estimated LODabs. As for the LOQabs, 
the correctness of the dilution series tested could be ascertained by the results observed 
for the analysis of the sample at 1 copy per reaction (see above LOQabs). Please note that 
an LODabs cannot be lower than 3 copies per reaction
36. 
A similar approach is based on modelling of the probability of detection (POD). This 
procedure is used for the assessment of the variability of the measured number of copies 
around LODabs
13. The repeatability standard deviations are compared to the theoretical 
values resulting from the Poisson model. A web-service2 allows computation of the LODabs 
and its confidence interval and of a mean POD curve with the corresponding 95 % 
confidence range36. 
Examples for possible test designs are given in Table 2. 
Acceptance criterion: The LOD should be in line with the validation data and/or the MPR 
document (< 25 copies with a level of confidence of 95 %)1. 
 
                                           
2 Web Service ‘Validation of qualitative PCR methods within a single laboratory’. 
https://quodata.de/content/validation-qualitative-pcr-methods-single-laboratory 
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Note: The practical LOD (LODprac) is out of the scope of this document because it is not a 
part of the verification of the method. Nevertheless, Annex 1 shows the relation between 
copy number and LODprac.  
 
Additional LOD acceptance criteria for multiplex qualitative PCR modules 
The LODasym for each module of a multiplex PCR method is determined by testing its 
analyte target at low amount or concentration (corresponding or close to the absolute 
LOD, i.e. not more than 25 copies/reaction) in the presence of increasing amounts of the 
other target(s) which are amplified in parallel by the other module(s) in the multiplex 
assay. The amount of other target(s) should not exceed 20,000 copies/reaction. 
The LODasym is expressed in absolute copies/reaction and is given for the corresponding 
amount of the other target(s) used in the tests. 
 
Procedure: The LODasym should already have been investigated in the context of method 
validation. For the verification at least one of the most critical combinations, according to 
the validation data, should be tested. It is recommended to test the analyte target at low 
amount (close to the absolute LOD, but not below) in the presence of high amount of the 
other target(s), e.g., not more than 25 copies/reaction of the target sequence in the 
presence of target DNA amplified in parallel by the other PCR module(s). The amount of 
other target(s) should not exceed 20,000 copies/reaction. 
Acceptance criterion: The LODasym should be in line with validation data.
 
Robustness 
Robustness should have been investigated already during method 
development/optimisation, before the method was subjected to a collaborative trial. 
Therefore, the robustness does not need to be re-evaluated in a verification study.  
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Table 1. Example of practical settings for the verification of a quantitative real-time PCR 
method 
1. Preliminary test 
to define 
appropriate DNA 
amount  
Optional: Test at least 3 target amounts in the range of 200 ng – 0.1 ng per 
reaction (dependent on plant species)37. 
For example: 200 ng soybean DNA corresponds to 176,991 soybean haploid 
genome copies with one haploid genome assumed to correspond to 1.13 pg 
of soybean genomic DNA38. This means that in standard curves made from 
e.g. 10 % (m/m) GMO soybean certified reference material 200 ng DNA 
corresponds to 176,991 copies of the endogenous gene target (if single 
copy) and to 17,699 copies of the GMO target (under the assumption that 
the material is homozygous for the GM locus), whereas 1 ng DNA 
corresponds to 885 copies of the endogenous gene target and 88 copies of 
the GMO target.  
2. Dynamic range, 
R2 coefficient, and 
amplification 
efficiency  
The method should only be used within its dynamic range. 
Example 1: Two calibration curves (minimum requirements) 
5 calibration points with 3 PCR replicates each (i.e., triplicates). 
All slopes shall be in the range of -3.6 ≤ slope ≤ -3.1 and all R2 values 
should be ≥ 0.98. 
Example 2: Four calibration curves 
5 calibration points with 2 PCR replicates each (i.e., duplicates); 
average of the 4 slopes and R2 are used to verify the acceptance.  
3. Trueness, RSDr 
At least 2 GM content levels (one around labelling threshold and one around 
LOQ, a third recommended to the upper part of the dynamic range). 
Example 1: Two DNA extraction replicates per GM level, 2 PCR replicates per 
extraction/plate, 4 plates resulting in 16 test results and 8 GM-content 
estimations per GM level* (Fig. 2). 
Example 2: Two DNA extraction replicates per GM level, 4 PCR replicates per 
extraction/plate, 2 plates resulting in 16 test results and 4 GM-content 
estimations per GM level* (Fig. 3). 
4. LOQ, LOD 
LOQ: 10 PCR replicates at a low content (e.g. 80, 60, 40, 20 copies and 1 
copy/reaction). LOQ is the lowest content of a series where the RSDr of the 
copy number measurements is below 25 %.  
If method is also used qualitatively:  
LOD: 10 PCR replicates at a low content (e.g. 20, 10, 5 copies and 1 copy 
per reaction). LOD is then the lowest content in a series where all replicates 
are positive. 
*If based on experience, the laboratory can prove that the repeatability among two experienced operators is 
the same as the repeatability among repetitions of one person, it is not necessary to have the repetition 
done by another operator. 
Note: It may be feasible to assess some of the parameters simultaneously in Table 1. 
Note: For a single assay the standard curve and the samples have to be on the same plate. Two assays (e.g. 
endogene and transgene assay) can be performed on two different plates using the same dilutions of the 
samples and having a standard curve on each plate.  
Note: If all 10 replicates for the 1 copy/reaction dilution are positive, the DNA content should be reassessed, 
because it is probably higher than expected. 
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Table 2. Example of practical setting for the verification of a qualitative real-time PCR 
method. 
1. Dynamic range, 
R2 coefficient, and 
amplification 
efficiency  
Optional: for examples see Table 1.2  
2. LOD 
Example 1: Test 10 PCR replicates around the expected LODabs (e.g. a 
serial dilution with 20, 10, 5, 3 copies and 1 copy/reaction)*. The LOD is 
the lowest content in the series where all replicates are positive. 
Example 2: Test six dilution levels (e.g. 20, 10, 5, 2, 1, 0.1 
copies/reaction) and 12 PCR replicates per level13. On basis of modelling a 
POD curve the LODabs at the 95 % confidence interval is computed (see 
https://quodata.de/content/validation-qualitative-pcr-methods-single-
laboratory)36.  
Example 3: Test 60 replicates at the concentration of the expected LODabs. 
The LOD at this concentration is verified if at least 59 replicates are 
positive34. This test relies on the knowledge and correctness of the DNA 
concentration (copies of the target sequence per volume solution 
measured). 
3. Specificity 
Optional if already assessed by validation study.  
Example for in silico evaluation: Verify the specificity of the method by use 
of the JRC GMO-Matrix interface30. Select the taxon(s) or specific GMO(s) 
and the PCR method to be tested and run the in silico simulation. The 
result of the simulation is a list of GMO events for which amplification by 
the method is predicted or not predicted. 
Example for experimental evaluation: Reference materials available for new 
GMO events that contain the target sequence are tested in duplicate using 
at least 100 copies/reaction of target DNA per PCR1. 
4. LODasym (Only for 
multiplex methods) 
At least, one of the most critical combinations according to the validation 
data should be tested.  
10 PCR replicates at a low amount of the target sequence (corresponding 
or close to the absolute LOD*) in the presence of high amount of another 
target(s) (e.g. 25 copies/reaction of one target sequence in the presence of 
a background of the other target(s) summed at the level of 20,000 
copies/reaction).   
 
*consider also LODasym from validation of the method 
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Figure 2: Experimental design for Trueness/Precision (example 1) 
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Figure 3: Experimental design for Trueness/Precision (example 2) 
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Annex 1: Effect of DNA content on the practical LOD 
As shown in Table 3, in a 0.1 % GM sample there are 1000 times more copies of the 
target-taxon specific sequence than of the GMO target. This implies that for an absolute 
LOD of the method of 10 copies, it is necessary to load in PCR 10,000 copies of the 
taxon-specific sequence to have a practical LOD of 0.1 %. If the absolute LOD is 10 
copies and 100,000 copies are loaded in the PCR reaction, then the practical LOD is 0.01 
% (see Table 3). The practical LOD should be calculated for each individual sample22.  
 
Table 3: Example of the effect of DNA content on the practical LOD 
Copies of taxon 
specific gene 
Absolute LOD 
(copies of GMO 
target) 
Practical LOD (%) 
100,000 10 0.01 
10,000 10 0.1 
1000 10 1 
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Annex 2: Evaluation of DNA- extraction method (Inhibition 
test) 
Background 
Substances known to inhibit the PCR reaction components affect the efficiency of target 
DNA amplification by interacting with the DNA template, by interfering with the DNA 
polymerase activity or decreasing the efficiency of enzymatic cofactors (Mg2+).  
DNA extraction procedures should eliminate or reduce considerably the amount of PCR-
inhibiting substances. However, the final amount of inhibitors in a sample depends very 
much on the sample nature and on the extraction procedure applied. Plant material may 
have secondary metabolites such as polyphenols, oils and polysaccharides which can 
form complexes with DNA strands and inhibitors can be added by the DNA isolation 
procedure: KCl and NaCl, ionic detergents, ethanol, isopropanol and phenol among 
others. 
Different strategies can be adopted to test DNA preparations for presence of PCR 
inhibitory compounds. This Annex illustrates the application of the ENGL acceptance 
criteria to evaluate reaction efficiency (slope and R2) of serially diluted samples from an 
undiluted source with the ability to test for presence of PCR inhibitors in the undiluted 
sample intended for the PCR analyses. 
Basically the inhibition depends on the concentration of the inhibitors. When DNA is 
diluted, the effect of inhibitors is often reduced or eliminated at lower DNA 
concentrations. Evaluation of the reaction efficiency on the diluted series and comparison 
of the theoretical Cq of a non-inhibited undiluted sample with its measured Cq, discloses 
information for the assessment of DNA quality for PCR applications. In case only the 
highest DNA concentration shows inhibition a lower DNA concentration can be used for 
quantification, but this will affect the practical LOD and LOQ. 
However, in certain cases, inhibitor compounds attached to DNA fragments may not be 
eliminated by sample dilution, thus resulting in less DNA copies available for amplification 
than expected from the nominal DNA concentration in a sample. 
 
Procedure 
DNA quality (relative absence of PCR inhibitors) can be demonstrated by analysing two 
PCR replicates using four points of a four-fold serial dilution (1:4, 1:16, 1:64 and 1:256) 
of each DNA extraction replicate (inhibition runs) using the taxon-specific reference 
system. The DNA extract is first brought to a level corresponding to the highest DNA 
concentration intended to be used in the subsequent PCR method, the so called 
‘undiluted’ sample (working DNA concentration). From this first sample, a four-fold 
dilution series is prepared (from 1:4 to 1:256). To assess the presence of inhibitors, the 
Cq values of the four serially diluted samples are plotted against the logarithm of the 
dilution factor and an equation is calculated by linear regression. The Cq value of the 
‘undiluted’ sample extrapolated from the linear regression is compared with the Cq 
measured from the same sample. To accept DNA extracts three conditions should be 
met: the slope of the regression line must be between -3.6 and -3.1; the coefficient of 
determination (R2) is equal to or above 0.98; and the difference between the measured 
Cq and the extrapolated Cq value (ΔCq) is below 0.5.  
The calculation sheet3 for the evaluation of the absence of PCR inhibitors is available as 
electronic supplementary material (http://gmo-crl.jrc.ec.europa.eu/guidancedocs.htm).  
Cq values from two PCR replicates from each dilution are necessary for running this test.  
                                           
3 This file was made available for educational purposes only. You may download this file and 
use it freely. The ENGL, JRC and the authors shall not be liable for any loss, damage etc. resulting 
from its use. 
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Evaluation of DNA quality 
In the figures below the wording ‘working DNA concentration’ in the blue cell reflects the 
term ‘undiluted sample’. 
 
Example A: Acceptable DNA quality: all criteria met 
 
 
Example B: DNA inhibited. Even though the Cq does not exceed the limit of 0.5 
(although it is close to this value) the underperforming DNA quality is demonstrated by 
the delay in reaction onset (Cq) for the undiluted sample and the 1:4 diluted sample. The 
latter affects the slope expressed by the serial dilution which appears flatter than 
acceptable (-3.0). 
 
 
Example C: DNA inhibited. This is another occurrence of low quality associated with the 
DNA extract. The slope of the dilution series is within the acceptance range, however, the 
extrapolated Cq for the undiluted sample (22.48), based on the four-point straight line 
should be lower than measured (23). This indicates a delay in onset for the undiluted 
sample which is less evident on the subsequent diluted sample 1:4. Therefore, while the 
slope of the linear regression falls within the range -3.6 to -3.1, the ΔCq demonstrated 
co-extraction of compounds inhibiting DNA amplification. 
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Example D: In this example, the slope of the regression line is out of the acceptance 
criteria (-3.66). However, contrary to example B, there is no delay in Cq onset for the 
undiluted sample and in the first samples of the dilution series. The ‘Cq’ column shows 
the measured difference in Cq values between subsequent samples of the dilution series. 
These values are always greater than the expected value of 2 for a reaction with 100 % 
efficiency. The dilution series behaves as if less DNA than calculated was present in the 
diluted samples. Therefore, we do not expect to classify this sample as affected by the 
presence of inhibitory compounds. However, if technical mistakes are ruled out (pipetting 
errors) and no other reasons are clearly identified, the possibility of inhibitors attached to 
DNA targets should not be discarded a priori.  
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Annex 3: Production of intermediate concentrations of 
positive material 
Some of the reference materials are only available in one or a few limited GM 
concentrations. It may be necessary to mix the positive material with non GM material to 
produce other GM concentrations e.g. for determining the relative LOQ and LOD. 
This can be done by measuring the content of the reference gene for the GM positive and 
a GM negative DNA preparation on the same plate with the same standard curve. 
Following this the dilution factor for the two DNA preparations can be calculated using the 
following formula:    
𝑋 = (
𝐴
𝐵
) (𝑌 − 1) + 1 
X = the practical dilution factor (how much the GM material has to be diluted 
compensated for difference in concentration) 
A = copy number of reference gene for the GM positive DNA preparation 
B = copy number of the reference gene for the GM negative DNA preparation 
Y = the theoretical dilution factor e.g. from 100 % GM to 10 % GM = 10x 
 
Example: 
DNA A = 100 % GMO,  
DNA B = 0 % 
5 µL DNA is added per PCR well for A and B 
  
Quantification as unknown sample on reference gene calibration curve 
Result: 
A (from DNA A): 10,000 copies/5 µL 
B (from DNA B): 8000 copies/5 µL 
  
To make 10 % GMO from 100 % GM corresponds to 10 times dilution (theoretically Y = 
10). 
X has to be used like Y in calculating the volumes to be mixed. If X=12.25, then practical 
dilution factor X: (10,000/8000)*(10-1)+1=((10,000/8000)*9) +1= 11.25+1= 12.25, so 
1 µl A has to be mixed with 11.25 µl B. 
After adding together the two DNA preparations, the DNA solution has to be mixed 
thoroughly. 
To prepare further dilutions:  
1 % GM can be made by diluting 1:10 the prepared 10 % solution with the 0 % solution.  
0.1 % GM can be made by diluting 1:10 the prepared 1 % solution with the 0 % 
solution. 
The DNA concentration of a 10 times diluted sample is close to the concentration of the 
original 0 % DNA preparation and this concentration can be used in the calculation of 
further dilutions. 
The trueness of the mixtures can be analysed using the 100 % mixture for standard 
curve and analysing 3 samples in triplicates on 3 times.  
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Annex 4: Estimation of the mean, standard deviation and 
relative repeatability standard deviation of GM-content from 
real time PCR 
The correct calculation of GM content and its standard deviation from PCR assays is in 
most experimental designs a two-step process combining mean values that are 
calculated in two different ways. The procedure outlined in detail below starts from the 
measured values of the copy numbers of target and reference genes. From these test 
results, an estimate of GM-content and a standard deviation is calculated. Most 
experimental procedures provide several such values (for example, from runs on the 
same or different plates) of GM content and standard deviation. These estimates can, if 
needed and appropriate, be combined in a standard way, for example by taking the 
arithmetic mean in case of the GM-content.  
 
Estimation of GM-content from copy numbers of target and reference genes 
Two assays are required to estimate the percentage of GM-DNA from samples using real-
time PCR: one assay is used to detect the copy number of the GM target DNA sequence 
(X), the other is used to determine the copy number of the endogenous reference gene 
DNA sequence (Y). The estimate of the percentage of GM content is obtained using the 
following ratio of  
%𝐺𝑀 =
𝑡𝑎𝑟𝑔𝑒𝑡 𝐷𝑁𝐴 𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟
𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝐷𝑁𝐴 𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 
100 =
𝑋
𝑌
100                 (1) 
 
Both X and Y are random variables. It is standard practice to run assays for the target 
and the reference genes in duplicates, triplicates etc. This results in 2, 3, etc. test results 
for the GM target DNA sequence and 2, 3, etc. test results for the reference gene DNA 
target sequence, and what is required is the calculation of an average GM-percentage 
from these two sets of test results. There are unfortunately no exact formula for the 
mean and variance of the ratio of random variables, but approximations do exist39. The 
mean, denoted by E[
𝑋
𝑌
], and the variance of a ratio of independent random variables are 
approximated by 
 
𝐸 [
𝑋
𝑌
] ≈
?̅?
?̅?
+
?̅?
?̅?3
𝑉𝑎𝑟(𝑦)               (2) 
And 
𝑉𝑎𝑟 [
𝑋
𝑌
] ≈ (
?̅?
?̅?
)
2
(
𝑉𝑎𝑟(𝑥)
?̅?2
+
𝑉𝑎𝑟(𝑦)
?̅?2
)                          (3) 
 
where  is the arithmetic mean of the target GM DNA copy numbers and is the 
arithmetic mean of the reference DNA copy numbers. 
These approximations assume that there is no correlation between X and Y. The standard 
deviation is given by . Relative repeatability standard deviation 
RSDr is calculated at the end of the procedure from the component standard deviations; 
the details of how to calculate RSDr are outlined in the examples below. 
 
x y
   YXVarYXsd 
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All these calculation can be implemented in Excel. 
 
Examples: 
In the examples, we use x for the copy number of the GM target gene and y for the copy 
number of the reference gene. These examples correspond to the examples given in 
Table 1 and demonstrate in detail the calculations needed for one plate and then describe 
how the calculation results from several plates are combined. 
 
Example 1: Two DNA- extractions, for each extraction both GM target and 
reference gene are tested in two PCR replicates on four plates 
This design provides two GM-estimates and standard deviations for each plate and thus 
eight GM-estimates (GM1-8) and eight standard deviations (sd1-8) in total. Each of these 
eight GM-estimates and standard deviations is derived using equations (1) and (2) from 
two test results each of the target gene copy number and the reference gene copy 
number. If the mean of all eight GM-estimates is taken, this average value depends on 
16 test results of the target gene copy number and 16 test results of the reference gene 
copy number; this also applies of course to the combined standard deviation. 
 
Extraction 1: 
GM target gene Reference gene 
Cq copy number Cq copy number 
24.41 16,119 21.30 156,758 
24.61 13,954 21.18 171,196 
 
Thus, , , Var(x) = 2343612.5 and Var(y) = 104,227,922. Putting 
the appropriate values into equation (2) gives a mean GM1 of 0.092 or 9.2 %; using 
equation (3) with the above values and taking the square root gives a standard deviation 
sd1 of 0.010943. 
 
Extraction 2: 
GM Target gene Reference gene 
Cq copy number Cq copy number 
25.50 13,405 21.10 172,089 
25.44 14,000 21.19 160,907 
 
Here, , , Var(x) = 177012.5 and Var(y) = 62518562. With the 
appropriate values, equation (2) gives a mean GM2 of 0.082 or 8.2 %; using equation (3) 
and taking the square root gives a standard deviation sd2 of 0.004654. 
 
Combining the plates 
This entire procedure is repeated on four different plates, giving in addition to GM1, GM2, 
sd1 and sd2 the means GM3, GM4,…, GM8 and the standard deviations sd3, sd4,…, sd8. 
The overall mean of the sample can then be calculated by taking the arithmetic 
mean of GM1 - GM8, i.e. 8
8
1



i
iGMGM . Using n as the number of replicates per 
97.15036x 163977y
5.13702x 166498y
GM
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extraction (n = 2 in this example) and k as the number of separate standard deviations 
to be pooled (k = 8 here), the standard deviation of the overall mean 
  





 

knsdnsd
i
i
i
iiGM
8
1
8
1
21 ; the term in the denominator is 16 – 8 = 8 in this 
example. The relative repeatability standard deviation . 
 
Example 2: Two DNA- extractions, both GM target and reference gene are tested 
in four PCR-replicates on two plates 
This design provides two GM-estimates and standard deviations for each plate and thus 
four GM-estimates (GM1-4) and four standard deviations (sd1-4) in total. Each of these 
four GM-estimates and standard deviations is derived using equations (1) and (2) from 
four test results each of the target gene copy number and the reference gene copy 
number. If the mean of all four GM-estimates is taken, the average value depends – as in 
example 1 above – on 16 test results of the target gene copy number and 16 test results 
of the reference gene copy number; this also applies of course to the combined standard 
deviation. 
 
Extraction 1: 
GM target gene Reference gene 
Cq copy number Cq copy number 
24.41 16,119 21.30 156,758 
24.61 13,954 21.18 171,196 
25.50 13,405 21.10 172,089 
25.44 14,000 21.19 160,907 
 
Here, , , Var(x) = 1433394 and Var(y) = 57,700,642. Applying 
equation (2) gives a mean GM1of 0.087 or 8.7 %; using equation (3) and taking the 
square root gives a standard deviation sd1 of 0.00828. 
 
Extraction 2: 
GM target gene Reference gene 
Cq copy number Cq copy number 
26.21 14,826.97 21.09 165,248 
26.30 13,885.92 21.09 165,248 
26.38 13,099.69 21.20 152,168 
26.20 14,935.39 21.25 146,569 
 
Here, , , Var(x) = 747,515 and Var(y) = 89,272,181. Applying 
equation (2) gives a mean GM2 of 0.091 or 9.1 %; using equation (3) and taking the 
square root gives a standard deviation sd2 of 0.0077. 
 
Combining the plates 
This entire procedure is repeated on two different plates, giving in addition to GM1, GM2, 
sd1 and sd2 the means GM3 and GM4 and the standard deviations sd3 and sd4 
100
GM
sd
RSD GMr 
5.14369x 5.165237y
14187x 157308y
  
26 
 
The overall mean of the sample can then be calculated by taking the arithmetic 
mean of GM1 - GM8, i.e. 4
4
1



i
iGMGM . Using n as the number of replicates per 
extraction (n = 4 in this example) and k as the number of separate standard deviations 
to be pooled (k = 4 here), the standard deviation of the overall mean 
  





 

knsdnsd
i
i
i
iiGM
4
1
4
1
21 ; the term in the denominator is 16 – 4 = 12 in this 
example. The relative repeatability standard deviation . 
 
Excel files for calculation of verification data 
Two Excel files for verification of quantitative real time PCR methods are available for 
download.  
In the Excel file ‘Method Verification Calculations RIKILT WUR.xlsx’4 (Supplemental 
Material 2) the Example 2 from Annex 4 can be found on the sheet named ‘Verification 
Doc example 2’. The Excel sheets with names ‘E R2 slope LOD’ and ‘bias RSDr’ contain an 
example with actual cotton validation data. In two identical plates are pipetted (see also 
Table 1): duplicate standard curves of 5 points (verification of Efficiency, R2, slope); 20, 
10, 5, 1 GMO copies/reaction in 5-fold (verification of LOD); 50 ng 1 % and 0.1 % GMO 
reference material from 2 DNA extractions in 4-fold (verification of bias and RSDr); DNA 
extraction control 2-fold; negative PCR control, water 2-fold. 
 
In the Excel file ‘Method Verification Calculations_Documentation BVL.xlsx’d 
(Supplemental Material 3) the Excel sheet ‘report’ contains all relevant data for the 
verification: e.g. information of the used material (e.g. species, target sequence/haploid 
genome copies, % GMO, DNA concentration of samples), PCR volume, template volume, 
equipment; Cq-values of PCR runs (Plate A-C); overview and evaluation of the 
acceptance criteria. The file includes Excel sheets for preparation of dilution series (Plate 
A-C); preparation of dilution of samples with GM level 1, GM level 2 and samples for 
specificity test; plate layout, preparation of reaction mix and cycling program (Plate A-C).  
Plate A: 3 calibration points with 3 PCR replicates (level A-C; e.g. 2.500, 500, 100 GMO 
copies) and 6 dilution levels with 10 PCR replicates around the expected LODabs (level D-
I; e.g. 60, 40, 20, 10, 5, 1 GMO copies). Plate B+C (two identical plates): triplicate 
standard curve of 5 points (verification of efficiency and R² coefficient); two GM level 
with 2 DNA extraction replicates and 4 PCR replicates per extraction (verification of 
trueness, precision and RSDr); PCR control reactions; new GMO events can be tested for 
specificity.  
 
  
                                           
4 These files were made available for educational purposes only. You may download these files and 
use them freely. The ENGL, JRC and the authors shall not be liable for any loss, damage etc. resulting 
from its use. 
GM
100
GM
sd
RSD GMr 
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